Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16263243rdf:typepubmed:Citationlld:pubmed
pubmed-article:16263243lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:16263243lifeskim:mentionsumls-concept:C0085243lld:lifeskim
pubmed-article:16263243lifeskim:mentionsumls-concept:C0003069lld:lifeskim
pubmed-article:16263243lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:16263243lifeskim:mentionsumls-concept:C0242632lld:lifeskim
pubmed-article:16263243lifeskim:mentionsumls-concept:C0205734lld:lifeskim
pubmed-article:16263243lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:16263243pubmed:issue3lld:pubmed
pubmed-article:16263243pubmed:dateCreated2005-11-21lld:pubmed
pubmed-article:16263243pubmed:abstractTextTo improve the feasibility of in vivo monitoring of autoreactive T cells in the diabetogenic process, we generated T1 and T2 doubly transgenic non-obese diabetic (NOD) mice in which transgenic human CD90 (hCD90) is simultaneously expressed on IFN-gamma-producing cells or murine CD90.1 (mCD90.1) is expressed on IL-4-producing cells. These transgenic NOD mice develop diabetes with the same kinetics and incidence as wild type NOD mice, permitting the physiological characterization of CD4(+)hCD90(+) cells, which represent T(H)1 cells in lymphoid organs and at the site of insulitis. CD4(+)hCD90(+) cells had a higher capacity to secret IFN-gamma than CD4(+)hCD90(-) cells in an autoantigen-specific manner. Transgenic mice treated with GAD65 plasmid were protected from autoimmune diabetes, and had a lower number of CD4(+)hCD90(+) cells, confirming the pathogenic role of CD4(+)hCD90(+) cells in autoimmune diabetes. To further investigate the effect of IL-12 on the development of T(H)1 cells in autoimmune diabetes, we crossed these doubly transgenic mice to IL-12p35-deficient NOD mice. Despite severe disturbance of diabetes in p35(-/-) mice, the frequency of T(H)1 cells in these mice was slightly lower than in wild type mice. These data support the pathological role of IL-12 in autoimmune diabetes and suggest the existence an IL-12-independent pathway of T(H)1 development.lld:pubmed
pubmed-article:16263243pubmed:languageenglld:pubmed
pubmed-article:16263243pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16263243pubmed:citationSubsetIMlld:pubmed
pubmed-article:16263243pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16263243pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16263243pubmed:statusMEDLINElld:pubmed
pubmed-article:16263243pubmed:monthNovlld:pubmed
pubmed-article:16263243pubmed:issn0896-8411lld:pubmed
pubmed-article:16263243pubmed:authorpubmed-author:KungJohn TJTlld:pubmed
pubmed-article:16263243pubmed:authorpubmed-author:HsiehShie-Lia...lld:pubmed
pubmed-article:16263243pubmed:authorpubmed-author:WuShu-FenSFlld:pubmed
pubmed-article:16263243pubmed:authorpubmed-author:McDevittHughHlld:pubmed
pubmed-article:16263243pubmed:authorpubmed-author:SytwuHuey-Kan...lld:pubmed
pubmed-article:16263243pubmed:authorpubmed-author:LinYu-ChungYClld:pubmed
pubmed-article:16263243pubmed:authorpubmed-author:HungJung-Tung...lld:pubmed
pubmed-article:16263243pubmed:authorpubmed-author:ChangTsung-Hs...lld:pubmed
pubmed-article:16263243pubmed:authorpubmed-author:LiaoJen-Hsian...lld:pubmed
pubmed-article:16263243pubmed:authorpubmed-author:ChangHsiu-Yin...lld:pubmed
pubmed-article:16263243pubmed:issnTypePrintlld:pubmed
pubmed-article:16263243pubmed:volume25lld:pubmed
pubmed-article:16263243pubmed:ownerNLMlld:pubmed
pubmed-article:16263243pubmed:authorsCompleteYlld:pubmed
pubmed-article:16263243pubmed:pagination181-92lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:meshHeadingpubmed-meshheading:16263243...lld:pubmed
pubmed-article:16263243pubmed:year2005lld:pubmed
pubmed-article:16263243pubmed:articleTitleImmunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model.lld:pubmed
pubmed-article:16263243pubmed:affiliationGraduate Institute of Life Sciences, National Defense Medical Center, 161, Section 6, MinChuan East Road, Neihu, Taipei 114, Taiwan.lld:pubmed
pubmed-article:16263243pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16263243pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:16159entrezgene:pubmedpubmed-article:16263243lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16263243lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16263243lld:pubmed